Send feedback

ABL1 p.Pro899=

c.2697G>A · rs367911374 · VCV2181280

Benign Single submitter
Classification
Benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0165%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -20GERP -2.7
Overall
CADD0.006PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0165% Middle Eastern · 1/6,068 alleles
Filtering AF 0.00723% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0055%
Overall 0.00323% 52/1,610,854 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0165% 6,068
African / African-American 0.0133% 7,493
East Asian 0.00892% 11,205
Remaining individualsnot grpmax-eligible 0.00803% 12,461
Admixed American 0.00335% 29,888
European (non-Finnish) 0.00254% 39,310

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ABL1
Protein
p.Pro899=
Coding
c.2697G>A
MANE Select
NM_005157
dbSNP
rs367911374
Type
single nucleotide variant
Location
chr9:130884987 (GRCh38)
Gene constraint
LOEUF 0.19 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 64.68 · 85 PDB
Residue 899
the 'disordered' region; the 'dna-binding' region
Full ABL1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abl1-p-pro899 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown